Is IGM Biosciences Inc halal to invest in?

As of July 2026, IGM Biosciences Inc IGMS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is IGM Biosciences Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes IGM Biosciences Inc using these criteria to determine its compliance status.

Can Muslims buy shares of IGM Biosciences Inc?

Muslim investors may consider investing in IGM Biosciences Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is IGM Biosciences Inc classified as HALAL?

Musaffa determines the Shariah status of IGM Biosciences Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for IGM Biosciences Inc updated?

The Shariah compliance status of IGM Biosciences Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like IGM Biosciences Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of IGM Biosciences Inc?

You can check the latest Shariah compliance status of IGM Biosciences Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

IGM Biosciences Inc IGMS

Last Updated: Aug 13, 12:00 AM·BE

IGMS Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, IGM Biosciences Inc is classified as halal.

HALAL

Report Source: 2025 2nd Quarter Report

IGM Biosciences Inc. Stock Analysis IGMS

Germany Health Care Micro Cap Report: Q2, 2025

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. The company is headquartered in Mountain View, California and currently employs 149 full-time employees. The company went IPO on 2019-09-18. The firm is engaged in developing and delivering a new class of medicines to treat patients with cancer and autoimmune and inflammatory diseases. The Company’s pipeline of clinical and preclinical assets is based on the IgM antibody, which has 10 binding sites compared to conventional IgG antibodies with only two binding sites. The company is also focused on creating, developing, manufacturing, and commercializing IgM antibody agonists against oncology and immunology and inflammation targets. The Company’s development programs include Aplitabart, Imvotamab, and IGM-2644. Aplitabart is an IgM antibody targeting Death Receptor 5 (DR5) proteins, being evaluated in multiple phase I combination trials for the treatment of colorectal cancer. Imvotamab is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 proteins. IGM-2644 is a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins.

Key Statistics of IGM Biosciences Inc (IGMS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€1.27€1.30

Today's Open

€1.30

Volume

1.61M

P/E Ratio (TTM)

52 Week Range

€1.25€1.33

Market Cap

67.58M

Avg. Volume

535.62K

Dividend Yield

Financial Metrics & Statements of IGM Biosciences Inc (IGMS)

Super Investors Invested in IGM Biosciences Inc (IGMS)

FAQ's for IGM Biosciences Inc (IGMS)

As of July 2026, IGM Biosciences Inc IGMS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes IGM Biosciences Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in IGM Biosciences Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of IGM Biosciences Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of IGM Biosciences Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of IGM Biosciences Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.